Ofloxacin

Ofloxacin is a racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication. Among its listed roles, it functions as a DNA synthesis inhibitor, an antiinfective agent, an antibacterial drug, an EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor and a topoisomerase IV inhibitor. It is a quinolone antibiotic, a fluoroquinolone antibiotic and a racemate. It includes a levofloxacin and a dextrofloxacin. It is grouped under the following drug class(es): Fluoroquinolones, QTc-prolonging agents, Quinolones and Topoisomerase inhibitors. Its therapeutic use is listed as anti-infectives, antibacterials, antibiotics, antituberculars and ophthalmic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Floxin, Oflocet, Visiren and Ofloxacinum. Its PubChem CID is 4583.

CAS No 82419-36-1
Molecular Formula C18H20FN3O4
Molecular Weight 361.4 g/mol
Synonyms 7-fluoro-2-methyl-6-(4-methylpiperazin-1-yl)-10-oxo-4-oxa-1-azatricyclo[7.3.1.05,13]trideca-5(13),6,8,11-tetraene-11-carboxylic acid

Frequently Asked Questions